India and China. The two most populous countries on the planet are also two of the most tantalizing markets for companies of all size, from startups to conglomerates. But those markets are also intensely, densely competitive: There's a lot of capital, a lot of players, and a whole lot of people. So do local players really have the home-court advantage here? Can they compete with the global players who have unparalleled execution ability and scale? And how does timing and structuring of companies entering those markets matter? Andreessen Horowitz partners Connie Chan and Anu Hariharan discuss these topics and more -- everything from logistics and infrastructure to design and talent -- on this episode of the a16z Podcast. As well as how domains like e-commerce, payments, and ride-sharing are playing out against the incredibly layered sociocultural backdrop of these two countries.

What if you could bring the best version of yourself to everything you do everyday? What if you could get the most out of your mind and brain -- or more scientifically, your "cognitive performance" -- without going to those old addictive standbys like coffee or RedBulls? The promise of nootropics or cognitive enhancers is to help us work better and more productively (for example, through more stamina and working memory); stay more awake and alert (without the sudden jolt of coffee); sleep better; and even protect our brains against cognitive impairments or neuro diseases like Alzheimer's. Geoffrey Woo and Michael Brandt, the founders of Nootrobox, believe that nootropics are possible for everyone -- not just for a select or hobbyist fringe of society -- and that part of that mainstreaming will involve a lot of hard science, hard data, and frankly, good user experience and better packaging of raw components ... the same things, in fact, that helped mainstream personal computers from the days of the early hacking at the Homebrew Club to Apple and the world of mass computing today. But how does nootropics move beyond a community movement ... and how does it fit into the context of other trends such as biohacking, quantified self, and more? Is the human body really the next 'platform'? All this and more on this episode of the a16z Podcast. The views expressed here are those of the individual AH Capital Management, L.L.C. (“a16z”) personnel quoted and are not the views of a16z or its affiliates. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by a16z. (An offering to invest in an a16z fund will be made only by the private placement memorandum, subscription agreement, and other relevant documentation of any such fund and should be read in their entirety.) Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by Andreessen Horowitz (excluding investments and certain publicly traded cryptocurrencies/ digital assets for which the issuer has not provided permission for a16z to disclose publicly) is available at https://a16z.com/investments/. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Please see https://a16z.com/disclosures for additional important information.